MP06-03 AMBULATORY PERCUTANEOUS NEPHROLITHOTOMY IS SAFE AND EFFECTIVE IN EXTENDED SELECTION CRITERIA PATIENTS

You have accessJournal of UrologyStone Disease: Surgical Therapy I (MP06)1 Sep 2021MP06-03 AMBULATORY PERCUTANEOUS NEPHROLITHOTOMY IS SAFE AND EFFECTIVE IN EXTENDED SELECTION CRITERIA PATIENTS Gregory Hosier, Kashif Visram, Michael Di Lena, Naji Touma, and Darren Beiko HosierGregory Hosier More articles by this author , VisramKashif Visram LenaMichael Lena ToumaNaji Touma BeikoDarren View All Author Informationhttps://doi.org/10.1097/JU.0000000000001973.03AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION OBJECTIVE: Ambulatory tubeless percutaneous nephrolithotomy (aPCNL) has been shown be safe effective in highly selected patients. However, these selection criteria preclude the vast majority patients that undergo PCNL. The objective our study was compare complication stone free rates after aPCNL standard vs. extended METHODS: Retrospective review prospective data on all who underwent at one academic center from 2007-2018. Extended were defined as any: Age >75 years, BMI >30 kg/m2, ASA >2, bilateral stones, solitary kidney, staghorn calculi, burden >40 mm, multiple tracts, or pre-existing nephrostomy tubes/stents. Primary outcomes (Clavien-Dindo classification) (no fragments >/=3 mm). discharged with a ureteric stent no tube meeting discharge which included hemodynamic stability, fever, significant pain. RESULTS: We identified 118 92 (78%) met criteria. Mean 31 kg/m2 45% 3 higher. sum maximum diameter 24 mm. Multiple stones present 25%, 7%, 4%, tubes/stents 4%. There difference (12% 18%, p=0.56), Emergency department visit vs readmission (4% 5%, p=1) between respectively (Table 1). Of complications, 85% Clavien-Dindo grade 1. Stone not different (84%) (83%) (p=1). No variables associated complications univariate analysis. mm (OR 5.8, 95% CI 1.4-25.2, p=0.018) tracts (13.1, 1.1-154.7, p=0.041) residual fragments. CONCLUSIONS: Complication undergoing aPCNL. This supports safety efficacy using As COVID-19 pandemic continues strain hospital resources, offers solution deal growing backlog complex disease. Source Funding: None © 2021 American Urological Association Education Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue Supplement 3September 2021Page: e89-e90 Advertisement Copyright & Permissions© Inc.MetricsAuthor Information Expand Loading ...